+39 02 610346.1 - info@newron.com Glossary | Sitemap | Cookie policy | Privacy policy Home About Us Research and Drug Development Investors and Media Contact Us ‹ › Success in CNS drug development – Innovation in Rare Diseases We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN). LATEST PRESS RELEASES 13 JUN Newron provides update on STARS clinical study with sarizotan for the treatment of Rett syndrome 29 MAY Newron Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference 15 MAY Newron Pharmaceuticals to Present at the UBS Global Healthcare Conference 2018 27 MAR Shareholders accepted all motions at the AGM 2018 1 MAR Newron announces 2017 financial results and provides outlook for 2018 13 FEB Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies View All NEWRON SHARE PRICE EVENTS 1 OCT Cantor Global Healthcare Conference October 1-3, 2018 - Intercontinental New York Barclay, New York, NY, USA 4 SEP H.C. Wainwright Annual Healthcare Conference September 4-6, 2018 - The St. Regis New York Hotel, New York, NY, USA 14 AUG Wedbush PacGrow Healthcare Conference August 14-15, 2018; Parker New York, New York, NY, USA View Event Calendar About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer ©2017 - Newron Pharmaceuticals SPA. All Rights Reserved - VAT: IT 02479490126

+39 02 610346.1 - info@newron.com Glossary | Sitemap | Cookie policy Home About Us Research and Drug Development Investors and Media Contact Us Press Releases Investors and Media / News News Events Stock Information Financial Calendar Shareholder FAQs Corporate Governance and Structure Downloads Email Alerts Filter by year 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2000 1999 may 15 2018 Newron Pharmaceuticals to Present at the UBS Global Healthcare Conference 2018 march 27 2018 Shareholders accepted all motions at the AGM 2018 march 1 2018 Newron announces 2017 financial results and provides outlook for 2018 february 13 2018 Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies february 8 2018 Change in the Board of Directors 1 2 Next About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer ©2017 - Newron Pharmaceuticals SPA. All Rights Reserved - VAT: IT 02479490126